Trademark applications and grants for Sol-gel Technologies Ltd.. Sol-gel Technologies Ltd. has 12 trademark applications. The latest application filed is for "CLER MICROPEARLS"
State Incorporated | ISRAEL |
Entity Type | CORPORATION |
Address | 7 Golda Meir St.,Weizmann Science Park, Ness Ziona, ISRAEL |
Patent Application | Date |
---|---|
TOPICAL JAK INHIBITOR COMBINATION COMPOSITIONS FOR TREATMENT OF INFLAMMATORY SKIN CONDITIONS 20220287990 - 17/629424 ARKIN; Moshe ;   et al. | 2022-09-15 |
TREATMENT OF HIDRADENITIS SUPPURATIVA WITH TAPINAROF COMPOSITIONS 20220202737 - 17/598271 ARKIN; Moshe | 2022-06-30 |
COMBINATION OF MINOCYCLINE AND BENZOYL PEROXIDE AND METHOD OF USE THEREOF 20220175802 - 17/440780 ARKIN; Moshe ;   et al. | 2022-06-09 |
TREATMENT OF ROSACEA WITH TOPICAL COMBINATION COMPOSITIONS 20220175732 - 17/440778 ARKIN; Moshe | 2022-06-09 |
TREATMENT OF SKIN DISORDERS WITH TOPICAL TAPINAROF-EGFR INHIBITOR COMPOSITIONS 20220142944 - 17/582273 ARKIN; Moshe ;   et al. | 2022-05-12 |
SEC | 0001684693 | Sol-Gel Technologies Ltd. of ISRAEL |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.